Results 181 to 190 of about 9,677 (231)
Some of the next articles are maybe not open access.
Perennial Allergic Rhinitis and Nasal Hyperreactivity
American Journal of Rhinology, 1998This article focuses on the nose as an accessible organ for research purposes, exploring whether the nose can be used to study lower airway processes.
openaire +3 more sources
Non-Allergic Perennial Rhinitis
2018Non-infectious rhinitis can broadly be subdivided into two subclasses, allergic and non-allergic rhinitis, depending predominantly on whether or not an allergic aetiology is implicated. The term 'non-allergic rhinitis' is commonly applied to a diagnosis of any nasal condition in which the symptoms are identical to those seen in allergic rhinitis but an
Jameel Muzaffar, Shahzada K. Ahmed
openaire +1 more source
Allergic rhinitis: A perennial burden
Practice Nursing, 1996The seriousness of allergic rhinitis and its impact on patients' lives is grossly underestimated. Glenis Scadding discusses the new guidelines and how practice nurses can ease the burden.
openaire +1 more source
Efficacy of montelukast for treating perennial allergic rhinitis
Allergy and Asthma Proceedings, 2007Perennial allergic rhinitis (PAR) is a chronic inflammatory nasal condition in individuals exposed year-round to allergens. This was a double-blind study of 15- to 85-year-old patients randomly allocated to montelukast, 10 mg (n=630), placebo (n=613), or the positive control cetirizine, 10 mg (n=122) for 6 weeks.
George, Philip +8 more
openaire +2 more sources
Control of nasal obstruction in perennial allergic rhinitis
Current Opinion in Allergy and Clinical Immunology, 2004Nasal obstruction, the cardinal symptom of persistent (perennial) allergic rhinitis, is one of the most common symptoms encountered in primary care and in specialist clinics. It is difficult to quantify by clinical examination, and, hence, objective assessment of the nasal airway is critical to rhinologic research.
De-Yun, Wang +2 more
openaire +2 more sources
The anticholinergic treatment of allergic perennial rhinitis
Journal of Allergy and Clinical Immunology, 1992Anticholinergic agents have been used for nonallergic rhinitis expressly to control rhinorrhea. In allergic rhinitis, rhinorrhea can be extremely troublesome and unresponsive to traditional pharmacotherapeutic rhinitis treatments. Anticholinergic agents, through their specific ability to decrease nasal secretory response, should have beneficial effects
openaire +2 more sources
Fexofenadine reduces nasal congestion in perennial allergic rhinitis
Allergy, 2001Background: Nasal congestion is the predominant symptom in perennial allergic rhinitis (PAR), and it seems to be mainly related to the late‐phase inflammatory events. The present pilot study aimed to evaluate the therapeutic effect exerted by fexofenadine in patients with PAR due to mite allergy.
G, Ciprandi +4 more
openaire +2 more sources
Ebastine in perennial allergic rhinitis.
Annals of allergy, 1992Oral ebastine, 10 mg once daily for seven days, and placebo were compared as treatment for active perennial allergic rhinitis in 151 patients in a multicenter, randomized, double-blind trial. Ebastine treatment produced a significant reduction in the incidence and severity of most symptoms associated with perennial rhinitis. Tolerability was similar in
C, Picado Vallés +5 more
openaire +1 more source
Evaluation of allergic etiology in perennial rhinitis.
Annals of allergy, 1985In 197 patients with perennial rhinitis, 49 patients (24.9%) were found to be allergic to perennial inhalant allergens, 37 patients (18.8%) allergic to seasonal allergens, 52 patients (26.4%) had food intolerance, 12 patients (6.6%) showed evidence of nasal infection, and in 46 patients (23.3%) etiology was undetermined.
E.A. Pastorello +7 more
openaire +2 more sources
Pet dander and perennial allergic rhinitis: Therapeutic options
Allergy and Asthma Proceedings, 2009Pet allergy may now be the most common perennial allergen in the United States based on recent skin-prick testing data. This trend corresponds with the rise (from 56 to 63%) in U.S. households having indoor pets over the past 10 years. Furthermore small, suspended, particulate animal allergens may be found in 90% of all homes and most public indoor ...
openaire +2 more sources

